Modeling neurodevelopmental disorders using human pluripotent stem cells (Q38204302)

31 August 2017

title

Modeling neurodevelopmental disorders using human pluripotent stem cells (English)

1 reference

neurodevelopmental disorder

31 August 2017

main subject

1 reference

1 reference

1 August 2014

1 reference

Stem Cell Reviews and Reports

31 August 2017

published in

1 reference

31 August 2017

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24728983%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24728983%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

494-511

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24728983%20AND%20SRC:MED&resulttype=core&format=json

Conceptual issues in neurodevelopmental disorders: lives out of synch

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Animal models of autism spectrum disorder (ASD): a synaptic-level approach to autistic-like behavior in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neuropathology and animal models of autism: genetic and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Cells in human postmortem brain tissue slices remain alive for several weeks in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neural progenitor cells from postmortem adult human retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Disease-specific iPS cell models in neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Self-formation of optic cups and storable stratified neural retina from human ESCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Cerebral organoids model human brain development and microcephaly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Epidemiology of neurodevelopmental disorders in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Classification of developmental delays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Theory of mind and neurodevelopmental disorders of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

A developmental and genetic classification for malformations of cortical development: update 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

The basics of brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Evolution, development, and plasticity of the human brain: from molecules to bones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Developmental origins of astrocyte heterogeneity: the final frontier of CNS development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Adult neural stem cells: plastic or restricted neuronal fates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Adult neural stem cells: an endogenous tool to repair brain injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neuronal plasticity: historical roots and evolution of meaning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Genetic and environmental factors in complex neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

The role of folic acid fortification in neural tube defects: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Disorders of prosencephalic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neurodevelopmental consequences of maternal distress: what do we really know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Fetal alcohol spectrum disorders: a practical clinical approach to diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Cerebral palsy-definition, classification, etiology and early diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Genetic susceptibility to neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

The contribution of rare diseases to understanding the epidemiology of neurodevelopmental disabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

A genetic model for neurodevelopmental disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Somatic mutation, genomic variation, and neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Worldwide survey of published procedures to culture human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Human embryonic stem cells carrying mutations for severe genetic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Substrates and supplements for hESCs: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Pluripotency in the embryo and in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Embryonic stem cells: from markers to market.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Human embryonic stem cells: current technologies and emerging industrial applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Good manufacturing practice and clinical-grade human embryonic stem cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Embryonic stem cells from morula

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Female sex bias in human embryonic stem cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Derivation, expansion, and characterization of human embryonic stem cell lines from aneuploid embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Mutated human embryonic stem cells for the study of human genetic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Human embryonic stem cells as a powerful tool for studying human embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Human embryonic stem cells as a model for early human development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Derivation and potential applications of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Human embryonic stem cells: the battle between self-renewal and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Human embryonic stem cells as a cellular model for human disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

PGD-derived human embryonic stem cell lines as a powerful tool for the study of human genetic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Personal pathways to embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Human embryonic stem cell lines with genetic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Derivation of new human embryonic stem cell lines from preimplantation genetic screening and diagnosis-analyzed embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Microarray-CGH for the assessment of aneuploidy in human polar bodies and oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Vitrified blastocysts from Preimplantation Genetic Diagnosis (PGD) as a source for human Embryonic Stem Cell (hESC) derivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Comparison of three embryo culture methods for derivation of human embryonic stem cells from discarded embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

A modified culture medium increases blastocyst formation and the efficiency of human embryonic stem cell derivation from poor-quality embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Derivation of human embryonic stem cell lines after blastocyst microsurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

High-efficiency derivation of human embryonic stem cell lines following pre-implantation genetic diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Effect of karyotype on successful human embryonic stem cell derivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Genetic manipulation of human embryonic stem cells: a system to study early human development and potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Genetic manipulation of human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Genetic manipulation of human embryonic stem cells in serum and feeder-free media

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Human fetal cortical and striatal neural stem cells generate region-specific neurons in vitro and differentiate extensively to neurons after intrastriatal transplantation in neonatal rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Pax6 promotes neurogenesis in human neural stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Isolation and propagation of primary human and rodent embryonic neural progenitor cells and cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Modeling neurodevelopmental disorders using human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Impact of induced pluripotent stem cells on the study of central nervous system disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Human ESC-derived neural rosettes and neural stem cell progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neural differentiation of Fragile X human Embryonic Stem Cells reveals abnormal patterns of development despite successful neurogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

In vitro recapitulation of neural development using embryonic stem cells: from neurogenesis to histogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Oct4-induced reprogramming is required for adult brain neural stem cell differentiation into midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

In vitro assays for neural stem cell differentiation: induction of dopaminergic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Patient-derived stem cells: pathways to drug discovery for brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Differentiation from human pluripotent stem cells of cortical neurons of the superficial layers amenable to psychiatric disease modeling and high-throughput drug screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Oligodendrogenesis from neural stem cells: perspectives for remyelinating strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Human oligodendrocytes derived from embryonic stem cells: Effect of noggin on phenotypic differentiation in vitro and on myelination in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Autism spectrum disorders: developmental disconnection syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Early identification of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Application of DSM-5 criteria for autism spectrum disorder to three samples of children with DSM-IV diagnoses of pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

21 January 2018

What is new in autism?

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neural systems approaches to the neurogenetics of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Disentangling the heterogeneity of autism spectrum disorder through genetic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Allele-biased expression in differentiating human neurons: implications for neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neuronal connectivity as a convergent target of gene × environment interactions that confer risk for Autism Spectrum Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neurons generated by direct conversion of fibroblasts reproduce synaptic phenotype caused by autism-associated neuroligin-3 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Derivation of autism spectrum disorder-specific induced pluripotent stem cells from peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Functional impacts of NRXN1 knockdown on neurodevelopment in stem cell models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Ion channel functional candidate genes in multigenic neuropsychiatric disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Mouse model of Timothy syndrome recapitulates triad of autistic traits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Calcineurin Controls Voltage-Dependent-Inactivation (VDI) of the Normal and Timothy Cardiac Channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Modeling Timothy syndrome with iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Timothy syndrome is associated with activity-dependent dendritic retraction in rodent and human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

The pathophysiology of fragile x syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

What can we learn about autism from studying fragile X syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Gender differences in neurodevelopmental disorders: autism and fragile x syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Lessons from fragile X regarding neurobiology, autism, and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

The FMRP regulon: from targets to disease convergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Timing of the absence of FMR1 expression in full mutation chorionic villi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Tissue-specific expression of a FMR1/beta-galactosidase fusion gene in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

FMRP targets distinct mRNA sequence elements to regulate protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neurodevelopmental disorders: Signalling pathways of fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Fragile X mental retardation protein and synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Subregion-specific dendritic spine abnormalities in the hippocampus of Fmr1 KO mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Behavioral and synaptic circuit features in a zebrafish model of fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Fragile X mental retardation protein regulates trans-synaptic signaling in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Molecular analysis of FMR1 reactivation in fragile-X induced pluripotent stem cells and their neuronal derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Altered differentiation of neural stem cells in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Genome-wide analysis validates aberrant methylation in fragile X syndrome is specific to the FMR1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Signaling defects in iPSC-derived fragile X premutation neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Rett syndrome: from bed to bench.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

The impact of MeCP2 loss- or gain-of-function on synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Epilepsy in Rett syndrome, and CDKL5- and FOXG1-gene-related encephalopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Rett syndrome: new clinical and molecular insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Rett syndrome: exploring the autism link

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

L1 retrotransposition in neurons is modulated by MeCP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Modeling Rett Syndrome with Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

A microRNA-based system for selecting and maintaining the pluripotent state in human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Isogenic pairs of wild type and mutant induced pluripotent stem cell (iPSC) lines from Rett syndrome patients as in vitro disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

MeCP2 regulates the synaptic expression of a Dysbindin-BLOC-1 network component in mouse brain and human induced pluripotent stem cell-derived neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

iPS cells to model CDKL5-related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Pathways to cognitive deficits in Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Systematic review of cognitive development across childhood in Down syndrome: implications for treatment interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neurological phenotypes for Down syndrome across the life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Clinical practice. The care of children with Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Alzheimer's disease and Down's syndrome: Treating two paths to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Role of tau protein in neuronal damage in Alzheimer's disease and Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Transchromosomal mouse embryonic stem cell lines and chimeric mice that contain freely segregating segments of human chromosome 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Microcell-mediated chromosome transfer (MMCT): small cells with huge potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Human embryonic stem cells as models for aneuploid chromosomal syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Trisomy correction in Down syndrome induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Deficits in human trisomy 21 iPSCs and neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Translating dosage compensation to trisomy 21

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

21 January 2018

Prader-Willi syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Genetic and epigenetic dysregulation of imprinted genes in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neurologic manifestations of Angelman syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neurobehavioral phenotype in Prader–Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11-q13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Induced Pluripotent Stem Cells Can Be Used to Model the Genomic Imprinting Disorder Prader-Willi Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader–Willi syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

The recognition of Lesch‐Nyhan syndrome as an inborn error of purine metabolism

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

21 January 2018

12 December 2020

Delineation of the motor disorder of Lesch-Nyhan disease

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neurotransmitter changes in the pathophysiology of Lesch-Nyhan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Levodopa is not a useful treatment for Lesch-Nyhan disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Modeling for Lesch-Nyhan disease by gene targeting in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Disease-specific induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Engineering of human pluripotent stem cells by AAV-mediated gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Purinergic signaling in human pluripotent stem cells is regulated by the housekeeping gene encoding hypoxanthine guanine phosphoribosyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Erosion of dosage compensation impacts human iPSC disease modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Gaucher disease: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neuronal forms of Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Neuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Generation of isogenic pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Converting human pluripotent stem cells to neural tissue and neurons to model neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Regulation of neural specification from human embryonic stem cells by BMP and FGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Functional neural development from human embryonic stem cells: accelerated synaptic activity via astrocyte coculture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Rapid single-step induction of functional neurons from human pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Investigating synapse formation and function using human pluripotent stem cell-derived neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Excessive mobility interrupted

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-014-9507-2

Ethics and moral philosophy in the initiation of IVF, preimplantation diagnosis and stem cells.

21 January 2018

1 reference

12 December 2020

Dynamic mutations: where are they now?

1 reference

12 December 2020

Gaucher disease and other storage disorders

1 reference

12 December 2020

Generation of neural stem cells from discarded human fetal cortical tissue

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of Lesch-Nyhan disease with S-adenosylmethionine: experience with five young Malaysians, including a girl

1 reference

12 December 2020

Unstable mutations in the FMR1 gene and the phenotypes

1 reference

12 December 2020

Reflections on the pathogenesis of Down syndrome

1 reference

12 December 2020

Genetic factors in the etiology of child psychiatric disorders.

1 reference

12 December 2020

Gliogenesis: historical perspectives, 1839-1985.

1 reference

12 December 2020

What is known about autism: genes, brain, and behavior

1 reference

12 December 2020

A human stem cell model of early Alzheimer's disease pathology in Down syndrome

1 reference

12 December 2020

Gender and age differences in the core triad of impairments in autism spectrum disorders: a systematic review and meta-analysis

1 reference

12 December 2020

The relationship of Rett syndrome and MECP2 disorders to autism.

1 reference

12 December 2020

A cut above the rest: targeted genome editing technologies in human pluripotent stem cells

1 reference

12 December 2020

Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006

1 reference

12 December 2020

Infection in pregnancy and cerebral palsy.

1 reference

12 December 2020

Synaptogenesis, heterochrony and epigenesis in the mammalian neocortex.

1 reference

12 December 2020

Neural stem cell systems: physiological players or in vitro entities?

1 reference

12 December 2020

Induced pluripotent stem cells to model and treat neurogenetic disorders

1 reference

12 December 2020

Gaucher disease: insights from a rare Mendelian disorder

1 reference

12 December 2020

Parkinson's disease in a dish - Using stem cells as a molecular tool.

1 reference

12 December 2020

Lesch-Nyhan disease and the basal ganglia

1 reference

12 December 2020

CNS development: an overview

1 reference

12 December 2020

Human embryonic stem cells: derivation, culture, and differentiation: a review

1 reference

12 December 2020

10.1007/S12015-014-9507-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24728983%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

13 June 2020

1027711814

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24728983%20AND%20SRC:MED&resulttype=core&format=json